ReviewCurrent pharmaceutical biotechnology2024
High Mobility Group Box 1 Protein: A Plausible Therapeutic Molecular Target in Parkinson's Disease.
Ahsas Goyal et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it